Lasa Supergenerics , the demerged entity of Omkar Speciality Chemicals, has commenced trial production at unit IV, situated at Chiplun. The Unit IV was earlier known as Unit V, the company said and added that it is geared up to take advantage of this opportunity and expand in line with their strategic plans. The planned production and capacity per annum includes Albendazole Intermediate, Fenbendazole Intermediate, 2 4 DCP, Closantel Intermediate and additionally a few components of backward integration for its recent new launches. Shares of Lasa Supergenerics, one of the leading players in the manufacturing of veterinary APIs, closed at ₹139.15, up 4.98 per cent on the NSE.
Zee Learn has informed the exchanges that the NSE has approved its proposal to reclassify some of its promoters as public shareholders. Earlier, promoters/promoter entities-Laxmi Narain Goel (nil stake), Ashok Goel (nil stake), Jawahar Lal Goel (nil stake), Ashok Kurien (0.19 per cent stake), Sushila Devi (0.06 per cent stake), Veena Investments Private Ltd (1.15 per cent stake), Ganjam Trading Company Private Ltd (1.66 per cent stake) and Ambience Business Services Private Ltd (0.21 per cent stake)-had made a proposal to the company to reclassify them as public shareholders. The proposal was approved by its shareholders in the Annual General Meeting in September. Shares of Zee Learn gained 0.56 per cent at ₹44.2 on the NSE.
Hitesh M. Shah, promoter of Renaissance Jewellery , on Monday sold 2,195 shares of the company (0.01 per cent of its paid-up capital) on the NSE at an average price of ₹192.92 a share. The selling was to meet the minimum public shareholding requirement of the company. Following the selling, the promoter holding will come to 75 per cent. Shares of Renaissance Jewellery jumped 8.7 per cent at ₹200.85 on the NSE.